Personalis
Deepshikha Bhandari currently serves as the SVP of Quality, Regulatory, and Clinical Compliance at Personalis, Inc., where focus is on strategic leadership in biopharma partnerships and compliance with various regulatory standards. Previous roles include Vice President of Regulatory Affairs at GRAIL, Inc., and Roche Molecular Systems, where Bhandari developed regulatory strategies for early cancer detection and digital health devices, respectively. Experience also includes leadership in regulatory affairs at Abbott Vascular, managing strategies for a range of medical devices and leading regulatory submissions globally. Deepshikha Bhandari holds an MBA in Health/Health Care Administration from The George Washington University, alongside degrees in Ancient Japanese Literature and Japan Area Studies.
Personalis
4 followers
Personalis is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider to the VA Million Veteran Program (MVP). In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis® ImmunoID NeXT Platform® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. The Personalis Clinical Laboratory is GxP-aligned as well as CLIA’88-certified and CAP-accredited.